Literature DB >> 6546207

TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma.

P Nanni, C de Giovanni, P L Lollini, G Nicoletti, G Prodi.   

Abstract

A metastasizing mouse cell line (TS/A), originated from a mammary adenocarcinoma which arose spontaneously in a BALB/c female retired breeder, has been established in vitro. It displayed a remarkable morphologic heterogeneity, which is evident in plastic adherent cultures (cell types ranging from epithelial-like to fibroblast-like) as well as in semi-solid agar cultures. The TS/A line exhibited the presence of specific cytoplasmic estradiol receptor, with a binding activity of 16 fmoles/mg cytosol protein. The in vivo growth pattern was as follows: a s.c. inoculum of 105 cells caused a 100 per cent tumor take and kill in syngeneic animals; mean survival time was 54 +/- 1 days; it did not show significant transplant immunogenicity in syngeneic animals; it was able to give rise to both spontaneous lung metastases and artificial lung colonies; it had a high capacity to grow in H-2 matched, minor histocompatibility antigen incompatible hosts (10(6) cells killed 100 per cent DBA/2 mice in 58 +/- 2 days). This line of spontaneous mammary tumor cells is proposed as a useful model for studies on the heterogeneity of the neoplastic population in relation to metastatic spread, on tumor immunogenicity, and on therapy of mammary neoplasia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6546207     DOI: 10.1007/bf00121199

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  13 in total

1.  Induction of immune responsiveness in a genetically low-responsive tumor-host combination by chemical modification of the immunogen.

Authors:  N Galili; D Naor; B Asjö; G Klein
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

2.  Heterogeneity of tumor cells from a single mouse mammary tumor.

Authors:  D L Dexter; H M Kowalski; B A Blazar; Z Fligiel; R Vogel; G H Heppner
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

3.  Source of tumor cells influences their immune recognition by H-2-matched mice.

Authors:  G Forni; L Varesio; M Giovarelli; S Landolfo
Journal:  Transplantation       Date:  1979-06       Impact factor: 4.939

4.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

5.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

6.  Second point: animal tumor models and their relevance to human tumor immunology.

Authors:  H B Hewitt
Journal:  J Biol Response Mod       Date:  1983

7.  Studies with a spontaneous murine tumour--I. Indetectibility of host immune resistance with tumour-activated elaboration of T cell stimulatory lymphokines in vitro.

Authors:  K D Chandradasa; J Blears
Journal:  Eur J Cancer Clin Oncol       Date:  1982-09

8.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

9.  Minor histocompatibility antigens do not enhance BALB/c anti-SV40 TASA response.

Authors:  P Nanni; C de Giovanni; M C Galli; S Grilli; P L Lollini; G Nicoletti; G Prodi
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

10.  Results of the Italian interlaboratory quality control program for estradiol receptor assay.

Authors:  S Fumero; G P Berruto; D Pelizzola; S Grilli; C Buttazzi; G Di Fronzo; E Ronchi; C Bozzetti; P Mori; G Concolino; A Marocchi; G Robustelli Della Cuna; C Zibera; G Cerrutti; A Ros; A Piffanelli
Journal:  Tumori       Date:  1981-08
View more
  55 in total

1.  Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice.

Authors:  Karoline Lipnik; Elisabeth Naschberger; Nathalie Gonin-Laurent; Petra Kodajova; Helga Petznek; Stefanie Rungaldier; Simonetta Astigiano; Silvano Ferrini; Michael Stürzl; Christine Hohenadl
Journal:  Mol Med       Date:  2010-02-05       Impact factor: 6.354

2.  Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.

Authors:  Weiquan Li; Lizhong Wang; Hiroto Katoh; Runhua Liu; Pan Zheng; Yang Liu
Journal:  Cancer Res       Date:  2011-01-28       Impact factor: 12.701

3.  Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent.

Authors:  Joshua F Heiber; Glen N Barber
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

4.  Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.

Authors:  Giovanni Germano; Simona Lamba; Giuseppe Rospo; Ludovic Barault; Alessandro Magrì; Federica Maione; Mariangela Russo; Giovanni Crisafulli; Alice Bartolini; Giulia Lerda; Giulia Siravegna; Benedetta Mussolin; Roberta Frapolli; Monica Montone; Federica Morano; Filippo de Braud; Nabil Amirouchene-Angelozzi; Silvia Marsoni; Maurizio D'Incalci; Armando Orlandi; Enrico Giraudo; Andrea Sartore-Bianchi; Salvatore Siena; Filippo Pietrantonio; Federica Di Nicolantonio; Alberto Bardelli
Journal:  Nature       Date:  2017-11-29       Impact factor: 49.962

5.  Optimized systemic dosing with CpG DNA enhances dendritic cell-mediated rejection of a poorly immunogenic mammary tumor in BALB/c mice.

Authors:  Quan Cai; Lyubov Kublo; Rachel Cumberland; William Gooding; Joseph Baar
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

6.  Paracrine effects of IL-4 transfection on TS/A adenocarcinoma cells mediate reduced in vivo growth.

Authors:  S Pacor; R Gagliardi; P Spessotto; G Zabucchi; G Sava
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

7.  The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions.

Authors:  Tsukasa Shibue; Mary W Brooks; M Fatih Inan; Ferenc Reinhardt; Robert A Weinberg
Journal:  Cancer Discov       Date:  2012-05-18       Impact factor: 39.397

8.  High-metastatic clones selected in vitro from a recent spontaneous BALB/c mammary adenocarcinoma cell line.

Authors:  P L Lollini; C de Giovanni; V Eusebi; G Nicoletti; G Prodi; P Nanni
Journal:  Clin Exp Metastasis       Date:  1984 Jul-Sep       Impact factor: 5.150

9.  Interferon-mediated enhancement of metastasis. Are MHC antigens involved?

Authors:  P L Lollini; C De Giovanni; B Del Re; G Nicoletti; G Prodi; P Nanni
Journal:  Clin Exp Metastasis       Date:  1987 Oct-Dec       Impact factor: 5.150

10.  Tumor radiosensitization by gene therapy against endoglin.

Authors:  M Stimac; U Kamensek; M Cemazar; S Kranjc; A Coer; G Sersa
Journal:  Cancer Gene Ther       Date:  2016-05-20       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.